Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. We were founded in 2014 to leverage recent advances in science and medicine to find optimal therapies. We seek to identify and develop late stage, de-risked medicines with significant potential.
Our rationale for developing these medicines is based on key insights from our scientific founders and confirmed in discussions with leading experts in the field. Our products are protected by strong intellectual property. We apply the most efficient processes to bring safe and effective therapies to patients.
We are based in New York City but have ...
Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. We were founded in 2014 to leverage recent advances in science and medicine to find optimal therapies. We seek to identify and develop late stage, de-risked medicines with significant potential.
Our rationale for developing these medicines is based on key insights from our scientific founders and confirmed in discussions with leading experts in the field. Our products are protected by strong intellectual property. We apply the most efficient processes to bring safe and effective therapies to patients.
We are based in New York City but have collaborators and are working with patients across the United States and around the globe.
-
Number of Employees:
25-100
-
Annual Revenue:
$1-10 Million